Krystal Biotech receives FDA approval for updated VYJUVEK label

Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access

Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial

The Lamkin Clinic announces new technology to treat depression and optimise mental health in Oklahoma

Lion TCR's LioCyx-M004 receives US FDA IND clearance for chronic hepatitis B following Fast Track and Orphan Drug Designations

Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China

EMA validates Daiichi Sankyo's ENHERTU type II variation application for HER2 positive metastatic solid tumours

Sanofi's SAR402663 granted FDA fast track designation for wet AMD

Implantica produces 10,000 RefluxStop units ahead of planned US launch

Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA

Ionis receives FDA Breakthrough Therapy designation for ION582 in Angelman syndrome

Atossa Therapeutics seeks Type C meeting with FDA to accelerate development of low-dose (Z)-endoxifen for breast cancer risk reduction

Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD

Phanes Therapeutics reports first BTC patient dosed in trial of spevatamig in combination with chemotherapy

Nuvalent presents zidesamtinib ARROS-1 clinical trial data for TKI Pre-treated patients with Advanced ROS1-positive NSCLC at WCLC 2025